(Q36102687)

English

Review on flavivirus vaccine development. Proceedings of a meeting jointly organised by the World Health Organization and the Thai Ministry of Public Health, 26-27 April 2004, Bangkok, Thailand

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Review on flavivirus vaccine development. Proceedings of a meeting jointly organised by the World Health Organization and the Thai Ministry of Public Health, 26-27 April 2004, Bangkok, Thailand (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

World Health Organization

0 references

0 references

0 references

1 reference

based on heuristic

inferred from title

author name string

Hombach J

1

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Barrett AD

2

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Cardosa MJ

3

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Deubel V

4

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Guzman M

5

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Kurane I

6

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Roehrig JT

7

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Sabchareon A

8

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Kieny MP

9

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

language of work or name

0 references

publication date

1 April 2005

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

21

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

2689-2695

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Dengue: an update

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.040

7 January 2021

Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.040

7 January 2021

Derivation and characterization of a dengue type 1 host range-restricted mutant virus that is attenuated and highly immunogenic in monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.040

7 January 2021

Dengue 2 PDK-53 Virus as a Chimeric Carrier for Tetravalent Dengue Vaccine Development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.040

7 January 2021

Alterations of pr-M cleavage and virus export in pr-M junction chimeric dengue viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.040

7 January 2021

Safety and immunogenicity of a three dose regimen of two tetravalent live-attenuated dengue vaccines in five- to twelve-year-old Thai children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.040

7 January 2021

Safety and efficacy of chimeric yellow Fever-dengue virus tetravalent vaccine formulations in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.040

7 January 2021

Substitution of the structural genes of dengue virus type 4 with those of type 2 results in chimeric vaccine candidates which are attenuated for mosquitoes, mice, and rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.040

7 January 2021

A Live, Attenuated Dengue Virus Type 1 Vaccine Candidate with a 30-Nucleotide Deletion in the 3' Untranslated Region Is Highly Attenuated and Immunogenic in Monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.040

7 January 2021

Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis anti

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.040

7 January 2021

Points to consider in the development of a surrogate for efficacy of novel Japanese encephalitis virus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.040

7 January 2021

West Nile virus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.040

7 January 2021

Identifiers

10.1016/J.VACCINE.2004.11.040

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36102687&oldid=1617971061"